UMP Healthcare Holdings Limited has issued a profit warning indicating an expected net loss of about HK$76.00 million for the financial year ended 30 June 2026 (FY2026), reversing the HK$32.00 million net profit recorded in FY2025.

Revenue for FY2026 is projected to remain broadly in line with the prior year; however, earnings have been hit by two main factors:

1. Non-cash impairment provisions: One-off write-downs of goodwill and property, plant and equipment are anticipated to be significantly higher than in FY2025. While these impairments reduce reported profit, management noted they do not affect cash flow or day-to-day liquidity.

2. Start-up costs for new Foshan centre: Staff and rental expenses rose due to the opening and initial ramp-up of an integrated healthcare centre in Foshan during FY2026, adding to operating costs.

The figures are based on the Board’s preliminary review of unaudited management accounts and remain subject to audit adjustments. UMP expects to release its full FY2026 results by the end of September 2026.

Shareholders and potential investors are advised to exercise caution when dealing in UMP shares.